Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate is a research paper published in Journal of Chromatography B (2022). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIDDK NIH HHS
Grant: P30 DK072482
NHLBI NIH HHS
Grant: R35 HL135816
NCATS NIH HHS
Grant: UL1 TR003096
NHLBI NIH HHS
Grant: K23 HL143167
National Center for Advancing Translational Sciences
National Heart Lung and Blood Institute
Cystic Fibrosis Foundation
National Institute of Diabetes and Digestive and Kidney Diseases
MeSH Terms
Keywords